These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34399433)

  • 1. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis.
    Wang TF; Carrier M; Fournier K; Siegal DM; Le Gal G; Delluc A
    Thromb Haemost; 2022 May; 122(5):830-841. PubMed ID: 34399433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOACs use in extreme body-weighted patients: results from the prospective START-register.
    Guarascio M; Bertù L; Donadini MP; Antonucci E; Palareti G; Ageno W
    Intern Emerg Med; 2023 Sep; 18(6):1681-1687. PubMed ID: 37301770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
    Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
    Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of direct oral anticoagulant in morbidly obese patients with atrial fibrillation: systematic review and meta-analysis.
    Thangjui S; Kewcharoen J; Yodsuwan R; Trongtorsak A; Thyagaturu H; Shrestha B; Winans ARM; Bischof E
    Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):325-335. PubMed ID: 33730164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
    Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
    Makam RCP; Hoaglin DC; McManus DD; Wang V; Gore JM; Spencer FA; Pradhan R; Tran H; Yu H; Goldberg RJ
    PLoS One; 2018; 13(5):e0197583. PubMed ID: 29795629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis.
    Grymonprez M; De Backer TL; Steurbaut S; Boussery K; Lahousse L
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):749-761. PubMed ID: 33428092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis.
    Cavallari I; Verolino G; Romano S; Patti G
    Thromb Haemost; 2020 Feb; 120(2):314-321. PubMed ID: 31785599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
    Li D; Chang P; Zhang H; Bai F; Wu Q
    Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
    Ballestri S; Romagnoli E; Arioli D; Coluccio V; Marrazzo A; Athanasiou A; Di Girolamo M; Cappi C; Marietta M; Capitelli M
    Adv Ther; 2023 Jan; 40(1):41-66. PubMed ID: 36244055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review.
    Zhao Y; Guo M; Li D; Xu W; Pan C; He C; Cui X
    Clin Appl Thromb Hemost; 2023; 29():10760296231153638. PubMed ID: 36760080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
    Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
    J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.